| scholarly article | Q13442814 |
| P50 | author | José A Aínsa | Q55298982 |
| Carlos Martín | Q55298992 | ||
| P2093 | author name string | Charles J Thompson | |
| Santiago Ramón-García | |||
| P2860 | cites work | A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis | Q28139874 |
| Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis | Q28486661 | ||
| The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis | Q28486807 | ||
| Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump | Q28486832 | ||
| The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol | Q28487116 | ||
| A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase | Q28487209 | ||
| The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis | Q28487506 | ||
| mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis | Q28487615 | ||
| Genetic requirements for mycobacterial survival during infection | Q29547599 | ||
| Comparative genomics of BCG vaccines by whole-genome DNA microarray | Q29618558 | ||
| Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement | Q29619839 | ||
| Analysis of a complete library of putative drug transporter genes in Escherichia coli | Q30724303 | ||
| Mycothiol-dependent proteins in actinomycetes. | Q34575027 | ||
| Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria | Q34647294 | ||
| Inducible NorA-mediated multidrug resistance in Staphylococcus aureus | Q35120701 | ||
| Efflux-mediated drug resistance in bacteria | Q35626332 | ||
| Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study | Q36161983 | ||
| Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. | Q36282656 | ||
| Role of mycobacterial efflux transporters in drug resistance: an unresolved question | Q36378353 | ||
| Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein | Q36483194 | ||
| Multidrug-resistance efflux pumps - not just for resistance | Q36538111 | ||
| Construction of a family of Mycobacterium/Escherichia coli shuttle vectors derived from pAL5000 and pACYC184: their use for cloning an antibiotic-resistance gene from Mycobacterium fortuitum. | Q36832457 | ||
| Alkalitolerance: a biological function for a multidrug transporter in pH homeostasis. | Q37557434 | ||
| A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates. | Q38302517 | ||
| Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy | Q39475894 | ||
| LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis | Q40903335 | ||
| Spread of extensively drug-resistant tuberculosis | Q43071312 | ||
| Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. | Q45898349 | ||
| Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. | Q46717882 | ||
| Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum | Q46864661 | ||
| The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action | Q47215316 | ||
| QacR is a repressor protein that regulates expression of the Staphylococcus aureus multidrug efflux pump QacA. | Q47859229 | ||
| Derivatives of pUC18 that have BglII sites flanking a modified multiple cloning site and that retain the ability to identify recombinant clones by visual screening of Escherichia coli colonies | Q48133372 | ||
| In vitro insertional mutagenesis with a selectable DNA fragment | Q48387759 | ||
| Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm | Q57539311 | ||
| The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis | Q73718237 | ||
| Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria | Q79990868 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 3675-3682 | |
| P577 | publication date | 2009-06-29 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth | |
| P478 | volume | 53 |
| Q40645861 | A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis. |
| Q37307531 | Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor |
| Q53698585 | Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D. |
| Q37385024 | Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations |
| Q28483756 | BC4707 is a major facilitator superfamily multidrug resistance transport protein from Bacillus cereus implicated in fluoroquinolone tolerance |
| Q39149523 | Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages. |
| Q64063950 | Changes in Intrinsic Antibiotic Susceptibility during a Long-Term Evolution Experiment with Escherichia coli |
| Q40635856 | Characterization of a Mycobacterium avium subsp. avium operon associated with virulence and drug detoxification. |
| Q47687876 | Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis |
| Q43226668 | Cholesterol acquisition by Mycobacterium tuberculosis |
| Q41151986 | Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni |
| Q54174160 | Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents. |
| Q92968619 | Does oxidative stress contribute to antituberculosis drug resistance? |
| Q35051649 | Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism |
| Q33868685 | Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents |
| Q89907750 | Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates |
| Q57656351 | Efflux Pumps in Mycobacteria: Antimicrobial Resistance, Physiological Functions, and Role in Pathogenicity |
| Q28543543 | Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates |
| Q38608754 | Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy |
| Q38084554 | Efflux pump-mediated resistance in chemotherapy |
| Q42151604 | Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates |
| Q33897837 | EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice |
| Q33824169 | Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance |
| Q42559018 | Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG. |
| Q28533721 | Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis |
| Q28543447 | In vitro activity of rifampicin and verapamil combination in multidrug-resistant mycobacterium tuberculosis |
| Q64081477 | Increased drug permeability of a stiffened mycobacterial outer membrane in cells lacking MFS transporter Rv1410 and lipoprotein LprG |
| Q38056146 | Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs |
| Q60956670 | Insights on Efflux Pumps and Their Implications in Drug Resistance and Virulence |
| Q33607162 | Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis |
| Q34215397 | LprG-mediated surface expression of lipoarabinomannan is essential for virulence of Mycobacterium tuberculosis |
| Q57656378 | Measuring Efflux and Permeability in Mycobacteria |
| Q40105935 | Microbial Offense vs Host Defense: Who Controls the TB Granuloma? |
| Q53149007 | Morphological changes and differentially expressed efflux pump genes in Mycobacterium tuberculosis exposed to a rifampicin and verapamil combination. |
| Q64228505 | Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in |
| Q28552338 | Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis |
| Q37980031 | Mycobacterium abscessus: a new antibiotic nightmare |
| Q40075126 | Mycobacterium tuberculosis Major Facilitator Superfamily Transporters |
| Q41374063 | Mycobacterium tuberculosis has diminished capacity to counteract redox stress induced by elevated levels of endogenous superoxide. |
| Q41613625 | Non-acid-fastness in Mycobacterium tuberculosis ΔkasB mutant correlates with the cell envelope electron density. |
| Q40330811 | Oxidative stress and TB outcomes in patients with diabetes mellitus? |
| Q37009017 | Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response |
| Q39431033 | Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis |
| Q33962631 | Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds |
| Q42128862 | Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis. |
| Q28487552 | Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery |
| Q47627516 | Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan |
| Q57166319 | The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase |
| Q41249257 | The multifaceted roles of antibiotics and antibiotic resistance in nature |
| Q40757709 | The mycobacterial P55 efflux pump is required for optimal growth on cholesterol |
| Q37277325 | The role of transport mechanisms in mycobacterium tuberculosis drug resistance and tolerance |
Search more.